Dr Martina Gabrielli is currently a recipient of BBSRC Fellowship (UKRI) studying the roles of extracellular vesicles (EVs) in synaptic dysfunction related to brain ageing. After a BSc and MRes in Medical Biotechnology and PhD in Pharmacological Sciences in 2016, all from the University of Milan, for years she has been a postdoctoral Researcher at the CNR Institute of Neuroscience (IN-CNR) in Vedano al Lambro (Italy), in Dr Claudia Verderio's laboratory of Cell-to-cell signalling in brain. There, she explored the role of EVs released by glial cells in brain physiology and inflammation/pathology, with a particular focus on their effects on the synapse. In the last years, she is investigating the role of microglial large EVs in the propagation of synaptic dysfunction in Alzheimer’s disease (AD), and the molecular mechanisms of EV-neuron interaction. In 2017, she won a Travel Grant Fellowship from Fondazione Veronesi to join Dr Arancio’s lab at Columbia University in New York (USA) for a brief period to work on this topic. Then, thanks to an Italian Multiple Sclerosis (MS) Foundation Senior Fellowship, she investigated the role of myeloid EVs in MS. Later, she has been part of PREMSTEM Horizon2020 project exploring the neuromodulating effects of hMSCs. She also followed a new line of research on the role of EVs in gut-brain axis in Epilepsy.
Dr Martina Gabrielli is currently a recipient of BBSRC Fellowship (UKRI) studying the roles of extracellular vesicles (EVs) in synaptic dysfunction related to brain ageing. After a BSc and MRes in Medical Biotechnology and PhD in Pharmacological Sciences in 2016, all from the University of Milan, for years she has been a postdoctoral Researcher at the CNR Institute of Neuroscience (IN-CNR) in Vedano al Lambro (Italy), in Dr Claudia Verderio's laboratory of Cell-to-cell signalling in brain. There, she explored the role of EVs released by glial cells in brain physiology and inflammation/pathology, with a particular focus on their effects on the synapse. In the last years, she is investigating the role of microglial large EVs in the propagation of synaptic dysfunction in Alzheimer’s disease (AD), and the molecular mechanisms of EV-neuron interaction. In 2017, she won a Travel Grant Fellowship from Fondazione Veronesi to join Dr Arancio’s lab at Columbia University in New York (USA) for a brief period to work on this topic. Then, thanks to an Italian Multiple Sclerosis (MS) Foundation Senior Fellowship, she investigated the role of myeloid EVs in MS. Later, she has been part of PREMSTEM Horizon2020 project exploring the neuromodulating effects of hMSCs. She also followed a new line of research on the role of EVs in gut-brain axis in Epilepsy.